USD 0.58
(-6.86%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 9.31 Million USD | -41.86% |
2022 | 16.01 Million USD | -38.11% |
2021 | 25.87 Million USD | 2521.07% |
2020 | 987 Thousand USD | 163.9% |
2019 | 374 Thousand USD | 3300.0% |
2018 | 11 Thousand USD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 FY | 9.31 Million USD | -41.86% |
2023 Q2 | 10.84 Million USD | -19.15% |
2023 Q3 | 8.16 Million USD | -24.7% |
2023 Q4 | 9.31 Million USD | 14.05% |
2023 Q1 | 13.4 Million USD | -16.26% |
2022 Q2 | 20.74 Million USD | -12.33% |
2022 Q3 | 18.27 Million USD | -11.93% |
2022 FY | 16.01 Million USD | -38.11% |
2022 Q1 | 23.66 Million USD | -8.53% |
2022 Q4 | 16.01 Million USD | -12.36% |
2021 Q1 | 6.46 Million USD | 555.27% |
2021 FY | 25.87 Million USD | 2521.07% |
2021 Q4 | 25.87 Million USD | 42.57% |
2021 Q3 | 18.14 Million USD | 207.86% |
2021 Q2 | 5.89 Million USD | -8.87% |
2020 Q2 | 492 Thousand USD | 0.0% |
2020 FY | 987 Thousand USD | 163.9% |
2020 Q1 | 492 Thousand USD | 31.55% |
2020 Q4 | 987 Thousand USD | 300.0% |
2020 Q3 | 246.75 Thousand USD | -49.85% |
2019 Q2 | 93.5 Thousand USD | 0.0% |
2019 Q1 | 93.5 Thousand USD | 3300.0% |
2019 Q4 | 374 Thousand USD | 0.0% |
2019 FY | 374 Thousand USD | 3300.0% |
2019 Q3 | 374 Thousand USD | 300.0% |
2018 Q2 | 2750.00 USD | 0.0% |
2018 Q4 | 2750.00 USD | 0.0% |
2018 FY | 11 Thousand USD | 0.0% |
2018 Q1 | 2750.00 USD | 0.0% |
2018 Q3 | 2750.00 USD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Accelerate Diagnostics, Inc. | 31.36 Million USD | 70.318% |
BrainsWay Ltd. | 62.97 Million USD | 85.216% |
Cerus Corporation | 197.74 Million USD | 95.292% |
Envoy Medical, Inc. | 7.64 Million USD | -21.859% |
electroCore, Inc. | 16.38 Million USD | 43.187% |
Helius Medical Technologies, Inc. | 7.69 Million USD | -21.035% |
IceCure Medical Ltd | 16.41 Million USD | 43.266% |
Inogen, Inc. | 326.19 Million USD | 97.146% |
OrthoPediatrics Corp. | 449.58 Million USD | 97.929% |
Lucid Diagnostics Inc. | 27.27 Million USD | 65.86% |
Monogram Orthopaedics, Inc. | 16.57 Million USD | 43.845% |
MaxCyte, Inc. | 268.27 Million USD | 96.53% |
NeuroOne Medical Technologies Corporation | 8.09 Million USD | -14.976% |
Nexalin Technology, Inc. | 3.63 Million USD | -156.339% |
Orthofix Medical Inc. | 925.31 Million USD | 98.994% |
PAVmed Inc | 33.11 Million USD | 71.889% |
Rapid Micro Biosystems, Inc. | 143.45 Million USD | 93.51% |
RxSight, Inc. | 182.55 Million USD | 94.9% |
Sight Sciences, Inc. | 166.65 Million USD | 94.413% |
SI-BONE, Inc. | 230.42 Million USD | 95.96% |
TELA Bio, Inc. | 78.04 Million USD | 88.071% |
Treace Medical Concepts, Inc. | 251.9 Million USD | 96.304% |
Vivos Therapeutics, Inc. | 10.73 Million USD | 13.234% |
Acutus Medical, Inc. | 53.96 Million USD | 82.746% |
Talis Biomedical Corporation | 98.34 Million USD | 90.533% |
Spectral AI, Inc. | 10.69 Million USD | 12.926% |
Nano-X Imaging Ltd. | 218.64 Million USD | 95.742% |
CVRx, Inc. | 115.22 Million USD | 91.92% |
DIH Holding US, Inc. Warrants | 58.66 Million USD | 84.129% |
PetVivo Holdings, Inc. | 3.11 Million USD | -198.852% |
Bioventus Inc. | 810.91 Million USD | 98.852% |
Venus Concept Inc. | 93.65 Million USD | 90.059% |
TriSalus Life Sciences, Inc. | 25.72 Million USD | 63.81% |
LivaNova PLC | 2.42 Billion USD | 99.617% |
908 Devices Inc. | 202.98 Million USD | 95.413% |
Alphatec Holdings, Inc. | 805.2 Million USD | 98.844% |
Nemaura Medical Inc. | 14.56 Million USD | 36.072% |
NeuroPace, Inc. | 107.65 Million USD | 91.352% |
LENSAR, Inc. | 69.58 Million USD | 86.621% |
Apyx Medical Corporation | 79.24 Million USD | 88.251% |
Cutera, Inc. | 346.29 Million USD | 97.312% |
STRATA Skin Sciences, Inc. | 42.01 Million USD | 77.842% |
BioSig Technologies, Inc. | 1.79 Million USD | -417.798% |
Anika Therapeutics, Inc. | 270.63 Million USD | 96.56% |
ClearPoint Neuro, Inc. | 42.66 Million USD | 78.177% |
Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 99.754% |
Axonics, Inc. | 719.92 Million USD | 98.707% |
Outset Medical, Inc. | 313.8 Million USD | 97.033% |
IRIDEX Corporation | 34.43 Million USD | 72.964% |
PROCEPT BioRobotics Corporation | 404.71 Million USD | 97.7% |
IRadimed Corporation | 92.15 Million USD | 89.898% |
Tivic Health Systems, Inc. | 5.25 Million USD | -77.198% |
INVO Bioscience, Inc. | 20.88 Million USD | 55.428% |
Telesis Bio, Inc. | 70.41 Million USD | 86.778% |
Viemed Healthcare, Inc. | 154.1 Million USD | 93.959% |
Varex Imaging Corporation | 1.24 Billion USD | 99.255% |
Quipt Home Medical Corp. | 247.4 Million USD | 96.237% |
Pulmonx Corporation | 178.95 Million USD | 94.797% |
Dynatronics Corporation | 25.94 Million USD | 64.11% |
Modular Medical, Inc. | 13.8 Million USD | 32.57% |
ReShape Lifesciences Inc. | 10.72 Million USD | 13.21% |
Semler Scientific, Inc. | 78.06 Million USD | 88.074% |
InMode Ltd. | 863.28 Million USD | 98.922% |
Bruker Corporation | 4.24 Billion USD | 99.781% |
Cytosorbents Corporation | 53.26 Million USD | 82.52% |
DexCom, Inc. | 6.26 Billion USD | 99.851% |
Align Technology, Inc. | 6.08 Billion USD | 99.847% |
Viveve Medical, Inc. | 25.91 Million USD | 64.072% |
ZimVie Inc. | 1.2 Billion USD | 99.228% |
Movano Inc. | 9.42 Million USD | 1.178% |
Cytek Biosciences, Inc. | 497.66 Million USD | 98.129% |
Nexalin Technology, Inc. | 3.63 Million USD | -156.339% |
DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | 84.129% |
Tandem Diabetes Care, Inc. | 952.65 Million USD | 99.023% |
Profound Medical Corp. | 43.68 Million USD | 78.689% |
Insulet Corporation | 2.58 Billion USD | 99.64% |
enVVeno Medical Corporation | 48.63 Million USD | 80.857% |
Surmodics, Inc. | 185.73 Million USD | 94.987% |
iCAD, Inc. | 41.41 Million USD | 77.522% |
Nuwellis, Inc. | 9.77 Million USD | 4.708% |
Biotricity, Inc. | 5.94 Million USD | -56.665% |
iRhythm Technologies, Inc. | 433.14 Million USD | 97.851% |
Aethlon Medical, Inc. | 8.24 Million USD | -12.903% |
InspireMD, Inc. | 47.64 Million USD | 80.459% |
PAVmed Inc. | 33.11 Million USD | 71.889% |
BIOLASE, Inc. | 35.1 Million USD | 73.477% |
Beyond Air, Inc. | 56.96 Million USD | 83.655% |
FONAR Corporation | 214.24 Million USD | 95.655% |
AxoGen, Inc. | 196.82 Million USD | 95.27% |
Vivani Medical, Inc. | 45.79 Million USD | 79.671% |
Tactile Systems Technology, Inc. | 281.43 Million USD | 96.692% |
Inari Medical, Inc. | 674.23 Million USD | 98.619% |
UFP Technologies, Inc. | 404.13 Million USD | 97.696% |
QT Imaging Holdings, Inc. | 23.39 Million USD | 60.211% |
Heart Test Laboratories, Inc. | 9.5 Million USD | 2.032% |
Tenon Medical, Inc. | 6.34 Million USD | -46.73% |
Autonomix Medical, Inc. Common Stock | 9.4 Million USD | 1.031% |
Co-Diagnostics, Inc. | 103.64 Million USD | 91.018% |
AdaptHealth Corp. | 4.61 Billion USD | 99.798% |
Sintx Technologies, Inc. | 15.36 Million USD | 39.408% |
NanoVibronix, Inc. | 6.67 Million USD | -39.497% |
Quanterix Corporation | 425.01 Million USD | 97.809% |
Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | 0.0% |
Sensus Healthcare, Inc. | 53.72 Million USD | 82.672% |
Pacific Biosciences of California, Inc. | 1.74 Billion USD | 99.467% |
TransMedics Group, Inc. | 706.04 Million USD | 98.681% |
ReWalk Robotics Ltd. | 63.19 Million USD | 85.267% |
NeuroMetrix, Inc. | 21.42 Million USD | 56.545% |
Hyperfine, Inc. | 94.19 Million USD | 90.117% |
Establishment Labs Holdings Inc. | 268.64 Million USD | 96.534% |
Biomerica, Inc. | 9.25 Million USD | -0.605% |
Bone Biologics Corporation | 3.73 Million USD | -149.079% |
AVITA Medical, Inc. | 144.33 Million USD | 93.55% |
Bluejay Diagnostics, Inc. | 4.86 Million USD | -91.228% |
Silk Road Medical, Inc | 265.3 Million USD | 96.491% |